Skip to main content
. 2019 Mar 21;6(5):854–862. doi: 10.1002/acn3.750

Table 1.

Demographics and disease types of study cohorts

Case # MS type Myelin status Disease duration (years) Age (years) Sex EDSS PMI (h) Study method
MS01 SPMS Myelinated/demyelinated 36 45 M 7 3 Microarray
MS02 SPMS Demyelinated 25 52 M 9.5 5
MS03 PPMS Myelinated/demyelinated 9 63 F 7.5 5
MS04 SPMS Myelinated 19 53 F 9 6
MS05 SPMS Myelinated/demyelinated 21 53 F 8 7
MS06 SPMS Myelinated/demyelinated 20 60 F 8 6
MS07 PPMS Myelinated/demyelinated 23 75 M 9 5 qPCR
MS08 SPMS Myelinated 26 69 F 8 6
MS09 SPMS Demyelinated 30 60 F 9 8
MS010 SPMS Myelinated 27 71 F 9.5 5
MS011 SPMS Myelinated/demyelinated 35 74 M 8 9
MS012 SPMS Demyelinated 37 59 F 9 5

SPMS, secondary‐progressive multiple sclerosis; PPMS, primary‐progressive multiple sclerosis; EDSS, expanded disability status scale; PMI, postmortem interval.